Legend Biotech Names Alan Bash Interim CEO After Huang Ying Steps Down
2026-07-27 10:53:04
Legend Biotech, a U.S.-listed company, said Huang Ying stepped down as chief executive officer and board director, effective July 24, 2026. He will stay on as an adviser through August to ensure a smooth transition, according to Jiemian News. The company’s board has appointed Alan Bash, the current president of CARVYKTI, as interim CEO and has started a formal search for a permanent successor.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
ESMA Adds 15 Crypto Companies to Interim MiCA RegisterNext article：
苹果财报前期权看多
